High Resolution and High Speed Multimodal Ophthalmic Imaging

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Knowledge of the pathogenesis of ocular conditions, a leading cause of blindness, has benefited greatly from recent advances in ophthalmic imaging. However, current clinical imaging systems are limited in resolution, speed, or access to certain structures of the eye. The use of a high-resolution imaging system improves the resolution of ophthalmoscopes by several orders of magnitude, allowing the visualization of many microstructures of the eye: photoreceptors, vessels, nerve bundles in the retina, cells and nerves in the cornea. The use of a high-speed acquisition imaging system makes it possible to detect functional measurements such as the speed of blood flow. The combination of data from multiple imaging systems to obtain multimodal information is of great importance for improving the understanding of structural changes in the eye during a disease. The purpose of this project is to observe structures that are not detectable with routinely used systems.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• People over 18

• Patient with a pathology affecting the eye or healthy volunteer

• Participant who signed the consent

• Beneficiaries of the health insurance

Locations
Other Locations
France
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
RECRUITING
Paris
Contact Information
Primary
Nabil BROUK
nbrouk@15-20.fr
+33 140021144
Backup
Azedine DJABALI
Adjabali@15-20.fr
+33 140021126
Time Frame
Start Date: 2019-07-03
Estimated Completion Date: 2027-07
Participants
Target number of participants: 1200
Treatments
Experimental: High-resolution retinal imaging through adaptive optics
High-resolution retinal imaging through adaptive optics, full field OCT and holographic systems
Sponsors
Leads: Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

This content was sourced from clinicaltrials.gov